{
  "spec_version": "4",
  "endpoint": "financials-segment",
  "stock_code": "6523",
  "company_name": "PHCホールディングス",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/6523/current/#revenue-mix",
  "api_url": "/api/6523/financials/segment.json",
  "updated": "2026-09-19",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/6523/current/#revenue-mix",
  "source": {
    "segment": {
      "primary": [
        "有価証券報告書（セグメント情報）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "セグメント区分は各期の開示区分をそのまま採録しており、期をまたいだ区分の連続性は保証しない"
    },
    "region": {
      "primary": [
        "有価証券報告書（所在地別・海外売上高）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "地域区分は各期の開示区分をそのまま採録している"
    }
  },
  "html_url": "https://the-shashi.com/tse/6523/current/#revenue-mix",
  "segment": [
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "ヘルスケアソリューション",
      "sales": 116096,
      "profit": 4514,
      "assets": null
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "糖尿病マネジメント",
      "sales": 108141,
      "profit": 23945,
      "assets": null
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "診断・ライフサイエンス",
      "sales": 79882,
      "profit": 508,
      "assets": null
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "ヘルスケアソリューション",
      "sales": 136286,
      "profit": 17017,
      "assets": null
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "糖尿病マネジメント",
      "sales": 109367,
      "profit": 23260,
      "assets": null
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "診断・ライフサイエンス",
      "sales": 92224,
      "profit": -14140,
      "assets": null
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "ヘルスケアソリューション",
      "sales": 133550,
      "profit": 9829,
      "assets": null
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "糖尿病マネジメント",
      "sales": 111826,
      "profit": 26737,
      "assets": null
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "診断・ライフサイエンス",
      "sales": 108774,
      "profit": -1065,
      "assets": null
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "ヘルスケアソリューション",
      "sales": 120282,
      "profit": -9446,
      "assets": null
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "糖尿病マネジメント",
      "sales": 101597,
      "profit": 16007,
      "assets": null
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "診断・ライフサイエンス",
      "sales": 129653,
      "profit": 5645,
      "assets": null
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "ヘルスケアソリューション",
      "sales": 128311,
      "profit": 9272,
      "assets": null
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "糖尿病マネジメント",
      "sales": 98692,
      "profit": 13888,
      "assets": null
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "診断・ライフサイエンス",
      "sales": 130920,
      "profit": 7248,
      "assets": null
    }
  ],
  "region": [
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "日本",
      "sales": 152044
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "欧州",
      "sales": 84813
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "北米",
      "sales": 67907
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "その他",
      "sales": 35686
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "日本",
      "sales": 150787
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "欧州",
      "sales": 90840
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "北米",
      "sales": 74841
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "その他",
      "sales": 39966
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "日本",
      "sales": 150491
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "欧州",
      "sales": 85813
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "北米",
      "sales": 75386
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "その他",
      "sales": 42208
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "日本",
      "sales": 156245
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "欧州",
      "sales": 84176
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "北米",
      "sales": 79011
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "region": "その他",
      "sales": 42161
    }
  ]
}